Global Vaping Illness Market, By Treatment (Antibiotics, Antivirals, Corticosteroids, Others), Diagnosis (Computed Tomography (CT) Scan, Chest X-Ray, Others), Symptoms (Shortness of Breath, Cough, Fever and Chills, Diarrhea, Vomiting, Headache, Rapid Heartrate, Dizziness, Chest Pain, Others), Dosage (Injection, Tablets, Others), Route of Administration (Oral, Intravenous, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2029.
Market Analysis and Insights Global Vaping Illness Market
Vaping illness market is expected to gain market growth in the forecast period of 2022-2029. Data Bridge Market Research analyses the market to account to grow at a CAGR of 4.90% in the above mentioned forecast period.
The term vaping refers to the act of smoking electronic cigarettes. It's also known as JUULing, juicing, and dabbing (the latter of which generally contains marijuana). Vaping-associated pulmonary injury (VAPI), also known as e-cigarette or vaping product usage related lung damage (EVALI), is an acute or subacute respiratory ailment characterized by a variety of clinicopathologic features that replicate a variety of pulmonary disorders.
The rise in the vaping illness will act as major driver that will results in the expansion of market’s growth. Another significant factor influencing the growth rate of vaping illness market is the rising healthcare expenditure. Furthermore, advancement in the medical technology, rising initiatives by public and private organisations to spread awareness and growing government funding are the factors that will expand the vaping illness market. Other factors such as increase in the demand for effective therapies and rising geriatric population will positively impact the vaping illness market’s growth rate. Additionally, high disposable income and changing lifestyle will result in the expansion of vaping illness market. Also, growing incidences of stress and anxiety will increase the use of vaping and further result in the enhancement of growth of vaping illness market
Moreover, the rise in the research and development activities and launch of effective therapies will provide beneficial opportunities for the vaping illness market in the forecast period of 2022-2029. Also, high unmet need of current treatment and developments in healthcare technology will escalate the growth rate vaping illness market in future.
However, high cost associated with the treatment and lack of infrastructure in low-income countries will impede the growth rate of vaping illness market. Additionally, complications involved with vaping illness such as acute respiratory distress syndrome, respiratory failure and others will hinder the vaping illness market growth. Less awareness will further challenge the market in the forecast period mentioned above.
This vaping illness market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Vaping illness market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Vaping Illness Market Scope and Market Size
The vaping illness market is segmented on the basis of treatment, diagnosis, symptoms, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of treatment, the vaping illness market is segmented into antibiotics, antivirals, corticosteroids and others.
- On the basis of diagnosis, the vaping illness market is segmented into computed tomography (CT) scan, chest x-ray and others.
- On the basis of symptoms, the vaping illness market is segmented into shortness of breath, cough, fever and chills, diarrhea, vomiting, headache, rapid heartrate, dizziness, chest pain and others.
- On the basis of dosage, the vaping illness market is segmented into injection, tablets and others.
- On the basis of route of administration, the vaping illness market is segmented into oral, intravenous and others.
- On the basis of end-users, the vaping illness market is segmented into clinic, hospital and others.
The vaping illness market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.
Vaping Illness Market Country Level Analysis
Vaping illness market is analyzed and market size information is provided by the country, treatment, diagnosis, symptoms, dosage, route of administration, end-users and distribution channel as referenced above.
The countries covered in the vaping illness market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the vaping illness market due to the presence of major key players, high disposable income and well-developed healthcare infrastructure in this region. Asia-Pacific is expected to grow during the forecast period of 2022-2029 due to the increasing patient pool, rising investment in the healthcare sector and growing government support.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Vaping illness market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Global Vaping Illness Market Share Analysis
Vaping illness market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to vaping illness market research.
Some of the major players operating in the vaping illness market are F. Hoffmann-La Roche Ltd., Novartis AG, AstraZeneca, Johnson & Johnson Private Limited, AbbVie Inc., Pfizer Inc., Sanofi, Aurobindo Pharma, Mylan N.V., GlaxoSmithKline plc, Cipla Inc., Sun Pharmaceutical Industries Ltd., Abbott, Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., UCB S.A., GW Pharmaceuticals plc., Sumitomo Dainippon Pharma Co., Ltd., Merck & Co., Inc., Eli Lilly and Company, Lupin, SHIONOGI & Co., Ltd., and LEO Pharma A/S, among others.
SKU-
